Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov-Dec;36(7):1460-1465.
doi: 10.12669/pjms.36.7.3345.

Letrozole is superior to clomiphene citrate in ovulation induction in patients with polycystic ovary syndrome

Mehmet Nafi Sakar  1 , Suleyman Cemil Oglak  2
Affiliations

Letrozole is superior to clomiphene citrate in ovulation induction in patients with polycystic ovary syndrome

Mehmet Nafi Sakar et al. Pak J Med Sci. 2020 Nov-Dec.

Abstract

Objective: This study was aimed to compare the clinical outcomes of ovulation induction (OI) by timed intercourse with letrozole (LTZ) and clomiphene citrate (CC).

Methods: Three hundred and twenty-three patients with polycystic ovary syndrome (PCOS) who underwent OI with LTZ or CC between February 2017 and November 2018 were included in this retrospective study. The patients were divided into two groups as the CC group (n=148) and the LTZ group (n=175). Endometrial thickness, follicular development, ovulation, clinical pregnancy, abortion, and live birth rates of the groups were analyzed.

Results: The mean endometrium thickness of the CC group was 7.1±1.7 mm, and the LTZ group was 8.6±1.8 mm (p<0.001). The ovulation rate per cycle was higher in the LTZ group (93.1%) in comparison with the CC group (83.8%) (p=0.013). Clinical pregnancy rates were 52% in the LTZ group, and 41.2% in the CC group (p=0.047). LTZ with 44% of live birth rate was superior to CC with a 33% live birth rate (p=0.029).

Conclusions: LTZ is an effective OI agent in PCOS patients. LTZ is superior to CC in terms of pregnancy rates and live birth rates. As a result, we recommend that LTZ should be the first-line treatment agent in patients with PCOS.

Keywords: Clomiphene citrate; Letrozole; Ovulation induction; Polycystic ovary syndrome.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Joham AE, Teede HJ, Ranasinha S, Zoungas S, Boyle J. Prevalence of infertility and use of fertility treatment in women with policystic ovary syndrome:data from a large community-based cohort study. J Womens Health (Larchmt) 2015;24(4):299–307. doi:10.1089/jwh.2014.5000. - PubMed
    1. Roy KK, Baruah J, Singla S, Sharma JB, Singh N, Jain SK, et al. A prospective randomized trial comparing the efficacy of Letrozole and Clomiphene citrate in induction of ovulation in polycystic ovarian syndrome. J Hum Reprod Sci. 2012;5(1):20–25. doi:10.4103/0974-1208.97789. - PMC - PubMed
    1. Dewailly D. Diagnostic criteria for PCOS:Is there a need for a rethink? Best Pract Res Clin Obstet Gynaecol. 2016;37:5–11. doi:10.1016/j.bpobgyn.2016.03.009. - PubMed
    1. Yousefi B, Rahbar E. Clomiphene citrate impairs the endometrial CD98 expression in ovariectomized and non-ovariectomized rats:Role of HCG. Int J Reprod Biomed (Yazd) 2019;17(6):385–394. doi:10.18502/ijrm.v17i6.4809. - PMC - PubMed
    1. Kurosawa T, Hiroi H, Momoeda M, Inoue S, Taketani Y. Clomiphene citrate elicits estrogen agonistic/antagonistic effects differentially via estrogen receptors alpha and beta. Endocr J. 2010;57(6):517–521. doi:10.1507/endocrj.k09e-368. - PubMed

LinkOut - more resources